[1]
V. Sharma, S. Chawla, S. Garg, and B. Singh, “Efficacy and Safety of Vildagliptin and Remogliflozin as Add-On Therapy to Metformin in Patients of Type 2 Diabetes Mellitus: An open-label comparative study”, Sultan Qaboos Univ Med J, vol. 1, no. 1, Jan. 2024.